Releuko

Generic name: (filgrastim-ayow)

Dosage Form: injection, soln

Medically reviewed by A Rash, MD. Last updated on Mar 23, 2022.

What is Releuko?

 Releuko Releuko is a granulocyte colony-stimulating factor that has been synthesized by humans (G-CSF). G-CSF is a chemical that the body produces. It promotes the proliferation of neutrophils, a kind of white blood cell vital to the body’s anti-infection defenses.

Mechanism of Action

Colony-stimulating factors are glycoproteins that stimulate hematopoietic cell proliferation, differentiation commitment, and certain end-cell functional activation by binding to particular cell surface receptors.

Monocytes, fibroblasts, and endothelial cells produce endogenous G-CSF, a lineage-specific colony-stimulating factor. G-CSF affects neutrophil progenitor proliferation, differentiation, and selected end-cell functions (including enhanced phagocytic ability, priming of the cellular metabolism associated with respiratory burst antibody-dependent killing, and increased expression of some cell surface antigens) in the bone marrow. G-CSF is not species-specific, and it has been demonstrated to have minimal direct in vivo or in vitro effects on hematopoietic cell types other than neutrophils’ generation or activity.

Who should not take Releuko

Do not take Releuko if you have had a serious allergic reaction to human G-CSFs such as filgrastim products or pegfilgrastim products.

Before you take Releuko

Talk to  your healthcare provider about all of your medical conditions, including if you:

Inform your doctor about all of your medications, including prescription and over-the-counter medications, vitamins, and herbal supplements.

How will I receive Releuko?

Releuko side effects

This  may cause serious side effects, including:

The most common side effects experienced in patients receiving Releuko include:

These are not all the possible side effects of Releuko. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store Releuko?

Keep Releuko and all medicines out of the reach of children.

General information about the safety

Medicines are sometimes recommended for reasons not indicated in the Patient Information booklet. Releuko should not be used for any ailment for which it has not been prescribed. Even if they have the same symptoms as you, do not give Releuko to others. It has the potential to hurt them. You can get information on Releuko written for healthcare professionals from your pharmacist or healthcare provider.

Display Panel

 

PRINCIPAL DISPLAY PANEL

 

Releuko

 

 

Releuko

 

Releuko

 

Releuko

 

 

Releuko

 

Releuko

 

 

Releuko

 

PRINCIPAL DISPLAY PANEL

 

 

Releuko

One Response

Leave a Reply